DSD-T211
Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T211
46,XY isolated 17,20-lyase deficiency due to compound heterozygous CYB5A variants (ambiguous genitalia, insufficient masculinization at puberty).
Case fields and evidence
- Category
-
Congenital adrenal hyperplasia (CAH)
- Age
-
Neonatal onset, followed up to adulthood
- Sex
-
Male (46,XY, ambiguous genitalia at birth)
- Karyotype
-
46,XY
- Genetics
-
CYP17A1
- Diagnosis
-
46,XY isolated 17,20-lyase deficiency due to compound heterozygous CYB5A variants (ambiguous genitalia, insufficient masculinization at puberty).
- Follow-up
-
Long-term follow-up showed stable testicular microlithiasis and persistent primary hypogonadism; transferred to adult endocrinology to continue testosterone replacement.
- General phenotype
-
Male phenotype; puberty started spontaneously but progression stalled, requiring testosterone replacement; at end of treatment Tanner P5/G5, testes 15–20 mL.
- Imaging
-
Testicular ultrasound from age 4 showed testicular microlithiasis, stable from childhood through puberty.
- Laboratory findings
-
Neonatal hCG-stimulated testosterone <0.3→0.6 nmol/L, androstenedione <0.8→0.8 nmol/L; cortisol 150 nmol/L, 17-OHP 24 nmol/L, LH 1.2 IU/L, FSH 1.8 IU/L; methemoglobin (MetHb) 0.104 mmol/mmol Hb (<0.01).
- Management
-
Intramuscular testosterone for 3 months during infancy; hypospadias repair and correction of penoscrotal transposition; long-term testosterone replacement from age 14; reduction mammoplasty at age 12.
- Pathology
-
Testicular biopsy showed only microliths (calcifications), no evidence of malignancy.
- Evidence level
-
See source
- Clinical history
-
See source
- Family history
-
See source
- External genital examination
-
See source
Cite this resource
DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T211 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T211?version=v1.4.0